Good morning, everyone. Our apologies for the late start but we are having technical difficulties and attempting to resolve them. Nonetheless, we are endeavoring to provide you with the usual flow of interesting items. Here are a few to get us all started. We hope your day goes well. As for us, we are going to down a much-needed cup of stimulation. Stay in touch...
Merck Drops Fast-Acting Claim For Allergy Pill (Dow Jones)
US Moves Toward Drug Development Center (Reuters)
Orphan Drug Discounts Ended For Kids Hospitals (New York Times)
Cephalon Buys Rights To Stem Cell Therapies (Bloomberg News)
Caraco Pharma Considers Going Private (Detroit News)
China To Prices On Some Drugs By 19 Percent (PharmaTimes)
Sanofi-Aventis Signs Licensing Deal For HIV Drug (Montreal Gazette)
1 Comment
Re: NIH doing R&D for drugs.
I have no love affair with pharma but this came to mind:
Life is a chess game, and looking a few plays ahead, the benefit to pharma seems huge but short lived, inviting government deeper into their operations. It's a little surprising. Maybe it's unavoidable, idk, just, they must know nothing is free. Starting with any tax relief for private sector industry for providing jobs, as republicans would argue. Going with this after reducing their own R&D. Then becoming, eventually, a government utility.
Maybe I'm wrong.